Science

Market Mover -: Editas Medicine, Inc. (EDIT)

Market Mover -: Editas Medicine, Inc. (EDIT)

(NASDAQ:EDIT) stock have an ABR of 2.33. For the current year the company's revenue estimates are $476.39 Million compared to low analyst estimates of $456.39 Million and high estimates of $517 Million according to the prediction of 15 analysts. On average, equities analysts expect that Editas Medicine will post ($2.84) earnings per share for the current year. During the same quarter in the prior year, the company earned ($0.80) EPS. A negative earnings surprise will usually result in a decline in share price.

TRADEMARK VIOLATION NOTICE: "Creative Planning Purchases 9,000 Shares of Editas Medicine, Inc". The company reported ($0.85) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.62) by $0.23. Editas Medicine had a negative return on equity of 63.29% and a negative net margin of 1,864.00%.

The counter witnessed a trading volume of 0.66 million shares versus an average volume of 1.66 million shares during last trading session. For the current quarter Frank's worldwide N.V. (NYSE:FI) has high EPS estimates of $-0.08 in contradiction of low EPS estimates of $-0.12.

EDIT has been the topic of a number of other reports. Vetr raised Editas Medicine from a "buy" rating to a "strong-buy" rating and set a $27.14 price objective for the company in a report on Monday, March 20th. Finally, SunTrust Banks, Inc. started coverage on Editas Medicine in a report on Thursday, July 13th. This is well above the stock's Wednesday closing price of $17.98 each. Five analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company's stock. Chardan maintained its investment rating on the stock at buy. "(EDIT) Will Announce Quarterly Sales of $2.88 Million" was first posted by Rincon Hill News and is the sole property of of Rincon Hill News. If you are viewing this news story on another publication, it was copied illegally and reposted in violation of U.S. & worldwide copyright & trademark legislation. Revenue for the quarter also killed consensus, coming in at $3.1 Million, compared to the consensus of 2.4 Million.

In associated news, executive Gerald Frank Cox purchased 4,000 stocks of the firms shares in a trade on early Fri, Jun 2nd. The shares were bought at an average price of $14.07 per share, for a total transaction of $492,450.00. Following the completion of the transaction, the director now directly owns 35,000 shares in the company, valued at $492,450. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

More news: Weekly Research Analysts' Ratings Changes for FS Investment Corporation (FSIC)
More news: Trump threatens Venezuela with military intervention
More news: Ram Reveals 2018 3500 Heavy Duty, The Segment's Most Powerful Pickup Truck

Director Kevin Bitterman let go of 1,000,000 shares at an average price of $17.00 on May 22nd. With 806,900 shares average volume, it will take short sellers 8 days to cover their EDIT's short positions. The disclosure for this sale can be found here.

The following firms have also recently changed their position in EDIT. State Street Corp now owns 105,167 shares of the company's stock worth $1,708,000 after buying an additional 2,476 shares during the period. Vanguard Group Inc. increased its stake in Editas Medicine by 47.0% in the first quarter. Hedge funds and other institutional investors own 67.76% of the company's stock. TD Asset Management Inc. now owns 33,770 shares of the company's stock worth $754,000 after buying an additional 2,800 shares in the last quarter. Finally, LMR Partners LLP purchased a new stake in Editas Medicine during the first quarter valued at approximately $3,419,000. Schwab Charles Investment Management Inc. boosted its position in shares of Editas Medicine by 8.4% in the first quarter. FMR LLC now owns 5,901,489 shares of the company's stock valued at $131,721,000 after buying an additional 403,099 shares in the last quarter.

Shares of Editas Medicine (EDIT) traded up 11.31% during trading on Wednesday, reaching $21.95. Trading volume was up 88.39% over the stocks average daily volume. Editas Medicine has a 12 month low of $12.43 and a 12 month high of $29.20. The company has market cap of $788.66 million.

Shares of the company are trading at $19.72 which is significantly above $17.07, the 50 day moving average and which is slightly above the 200 day moving average of $18.99. Lastly, Cowen and Company reiterated a "buy" recommendation on stocks of Editas Medicine in a note on Wed, Mar 15th.


  • Solar Eclipse by the numbers

    Experts recommend being careful when it comes to buying glasses or viewers through a third-party seller, such as Ebay or Amazon . You should never look at an eclipse with the naked eye, but there are plenty of other unsafe methods to avoid, as well.
    The Twenty-First Century Fox, Inc

    The Twenty-First Century Fox, Inc

    Also, it has an estimated price-earnings (P/E) multiple of 15.3 and a trailing 12-month price-earnings (P/E) multiple of 24.24. The value of the investment in (FOXA) decreased from $2,010,000 to $835,000 a change of $1,175,000 for the reporting period.
    United States  has been conducting back-channel talks with North Korea for months

    United States has been conducting back-channel talks with North Korea for months

    But if North Korea escalates, the USA must be prepared to escalate to massive disarming strikes, including use of nuclear weapons. Heretofore, the administration has urged China to press North Korea as a kind of subcontractor to achieve American objectives.
  • Korean stocks down 1.1 pct on heightened tensions over N. Korea

    Korean stocks down 1.1 pct on heightened tensions over N. Korea

    Japan is the world's biggest creditor country and there is an assumption investors there will repatriate funds in a crisis. The remarks, following North Korea's earlier revelation of a plan to launch a salvo of ballistic missiles toward the U.S.
    As tensions with North Korea escalate, Trump retweets several comparisons with Obama

    As tensions with North Korea escalate, Trump retweets several comparisons with Obama

    As if they had the Trump insignia painted on them and tourists could pick up souvenir versions in the gift shop off the Trump Tower lobby.

    FTSE ends down as shares hit by US-North Korea tensions

    In the eurozone, the Paris CAC 40 dropped nearly 0.7 percent to 5,081.92 points compared with the closing level on Thursday. By the close of trading, the FTSE 100 was down 84.46 points, or 1.1%, to 7,305.48, having dropped 1.4% on Thursday.
  • Tigers' slump continues with loss to Twins

    Tigers' slump continues with loss to Twins

    He worked the count to 2-0 and then watched as Minnesota Twins reliever Matt Belisle threw an effective slider. Rockies center fielder Charlie Blackmon went 4 for 5 with two runs scored and two stolen bases.
    Stephen Jones: Zeke ban won't affect preseason snaps

    Stephen Jones: Zeke ban won't affect preseason snaps

    The proceedings over the league's punishment could then "drag out a long time", Robinson noted. The Cowboys have not announced whether Elliott will play at all during the preseason.
    Usain Bolt's final race ends in shock injury

    Usain Bolt's final race ends in shock injury

    He added: "I think the public have probably heard enough about us being the best generation of sprinting, with no results". It made for the most dramatic, unexpected and disappointing end to the career of the most decorated athlete ever.
  • Soccer Saturday pundits provide their predictions for the new Premier League season

    Soccer Saturday pundits provide their predictions for the new Premier League season

    Why hasn't he just said I'm staying for one more season? "We go to sign and other clubs are always going to ask us for more". Manchester City boss Pep Guardiola outlines his long-term vision for the club as he enters his second season.

    Navios Maritime Acquisition Corp (NYSE:NNA) Sentiment Improved in 2016 Q4

    First Allied Advisory Services invested 0.03% in Scripps Networks Interactive, Inc. (NYSE:GES) rating on Thursday, March 16. Wall Street is only getting more bullish on the stock, with 4 of analysts who cover NMM having a buy-equivalent rating.
    S&P falls 1.4 pct in safety flight on N. Korea tensions

    S&P falls 1.4 pct in safety flight on N. Korea tensions

    South Korea's KOSPI fell 1.8 percent to an 11-1/2-week low, but its losses for the week are a relatively modest 3.2 percent. When Iraq invaded Kuwait 27 years ago this month, the S&P 500 fell 1.1 percent, and was down 9.3 percent 20 days later.